Valuation Castle Biosciences, Inc.
Stocks
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
16:00:00 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 33.30 USD | +0.67% |
|
+3.53% | -14.40% |
Company Valuation: Castle Biosciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,103 | 620.3 | 580.7 | 746.4 | 1,135 | 1,017 | - | - |
| Change | - | -43.76% | -6.38% | 28.53% | 52.12% | -10.4% | - | - |
| Enterprise Value (EV) | 773.4 | 361.7 | 337.6 | 746.4 | 1,135 | 1,017 | 1,017 | 1,017 |
| Change | - | -53.23% | -6.65% | 121.07% | 52.12% | -10.4% | 0% | 0% |
| P/E | -34.6x | -9.12x | -10.1x | 43x | -46.9x | -26.5x | -36.5x | -93.8x |
| PBR | 2.62x | 1.54x | 1.48x | 1.71x | 2.39x | 2.14x | 2.07x | - |
| PEG | - | -0x | 0.6x | -0x | 0x | -0.5x | 1.3x | 1.5x |
| Capitalization / Revenue | 11.7x | 4.53x | 2.64x | 2.25x | 3.3x | 2.72x | 2.47x | 2.21x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.72x | 2.47x | 2.21x |
| EV / EBITDA | -0x | -0x | -0x | 0x | 0x | 89.1x | 40.7x | 22.9x |
| EV / EBIT | -0x | -0x | -0x | 0x | -0x | -22x | -31.8x | -69.5x |
| EV / FCF | -0x | -0x | -0x | 0x | 0x | -47.3x | 76.2x | 35x |
| FCF Yield | -2.04% | -7.62% | -3.31% | 4.9% | 2.49% | -2.11% | 1.31% | 2.86% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.24 | -2.58 | -2.14 | 0.62 | -0.83 | -1.258 | -0.9133 | -0.355 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 94.08 | 137 | 219.8 | 332.1 | 344.2 | 373.5 | 412.5 | 461.4 |
| EBITDA 1 | -36.67 | -62.31 | -55.65 | 74.99 | 43.85 | 11.42 | 24.98 | 44.39 |
| EBIT 1 | -40.08 | -72.86 | -67.98 | 8.67 | -42.81 | -46.18 | -31.99 | -14.64 |
| Net income 1 | -31.29 | -67.14 | -57.47 | 18.24 | -24.16 | -37.43 | -24.56 | -7.809 |
| Net Debt | -329.6 | -258.6 | -243.1 | - | - | - | - | - |
| Reference price 2 | 42.87 | 23.54 | 21.58 | 26.65 | 38.90 | 33.30 | 33.30 | 33.30 |
| Nbr of stocks (in thousands) | 25,730 | 26,352 | 26,911 | 28,007 | 29,189 | 30,550 | - | - |
| Announcement Date | 2/28/22 | 2/28/23 | 2/28/24 | 2/27/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -26.3x | - | - | - | 1.01B | |
| 34.01x | 4.08x | 15.69x | 2.48% | 179B | |
| 23.84x | 4.68x | 16.31x | 1.17% | 118B | |
| 20.4x | 3.54x | 12.67x | 2.97% | 117B | |
| 31.64x | 3.06x | 12.36x | 2.24% | 93.26B | |
| 18.15x | 0.21x | 13.14x | 0.72% | 63.16B | |
| 31.42x | 7.87x | 20.23x | 1.26% | 55.68B | |
| 39.45x | 3.63x | 12.37x | 2.1% | 54.18B | |
| 37.95x | 9.42x | 26.36x | -.--% | 44.15B | |
| 40.74x | 3.29x | 12.28x | 0.53% | 33.95B | |
| Average | 25.13x | 4.42x | 15.71x | 1.5% | 75.94B | |
| Weighted average by Cap. | 29.38x | 4.16x | 15.26x | 1.83% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CSTL Stock
- Valuation Castle Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
